Oral Midodrine Administration During the First 24 Hours of Sepsis to Reduce the Need of Vasoactive Agents: Placebo-Controlled Feasibility Clinical Trial-Reference-Cited by-同舟云学术

Oral Midodrine Administration During the First 24 Hours of Sepsis to Reduce the Need of Vasoactive Agents: Placebo-Controlled Feasibility Clinical Trial

Published:2021-05 Issue:5 Volume:3 Page:e0382
ISSN:2639-8028
Container-title:Critical Care Explorations
language:en
Short-container-title:

Author:

Lal Amos,Trivedi Vrinda,Rizvi Mahrukh S.,Amsbaugh Amy,Myers Melissa K,Saleh Khaled,Kashyap Rahul,Gajic Ognjen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference40 articles.

1. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations.;Fleischmann;Am J Respir Crit Care Med,2016

2. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals.;Rhee;JAMA Netw Open,2019

3. Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level.;Paoli;Crit Care Med,2018

4. Severe sepsis and septic shock.;Angus;N Engl J Med,2013

5. Pathophysiology of sepsis-related cardiac dysfunction: Driven by inflammation, energy mismanagement, or both?;Drosatos;Curr Heart Fail Rep,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Midodrine for the early liberation from vasopressor support in the ICU (LIBERATE): A feasibility study;2024-04-30

2. Exploring the Efficacy of Midodrine for Tapering Off Vasopressors;Cureus;2024-02-28

3. Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?;Cleveland Clinic Journal of Medicine;2023-10

4. CHARACTERISTICS AND PREDICTORS OF PATIENTS WITH SEPSIS WHO ARE CANDIDATES FOR MINIMALLY INVASIVE APPROACH OUTSIDE OF INTENSIVE CARE UNIT;Shock;2023-03-08

5. Utility of Midodrine During the Recovery Phase of Shock: A Systematic Review and Meta-analysis of Randomized Controlled Trials;American Journal of Therapeutics;2023-02-28